porcin
epidem
diarrhea
viru
pedv
enter
coronaviru
caus
diarrhea
vomit
sever
dehydr
death
pig
neonat
pig
particularli
suscept
mortal
rate
high
older
pig
manifest
diseas
milder
growth
product
paramet
affect
classic
strain
pedv
strain
first
detect
uk
spread
asia
europ
recent
highli
virul
strain
strain
emerg
china
spread
countri
first
case
us
record
estim
outbreak
result
loss
billion
death
million
pig
avail
effect
vaccin
practic
stringent
biosecur
measur
critic
prevent
pedv
howev
develop
effect
vaccin
complic
frequent
viral
evolut
fact
ped
sever
immunolog
neonat
effect
safe
vaccin
develop
also
challeng
activ
vaccin
replic
gut
requir
induc
good
last
mucos
immun
attenu
inactiv
pedv
vaccin
routin
use
asian
countri
sever
year
vaccin
sow
prior
farrow
induc
lactogen
immun
transfer
neonat
piglet
via
colostrum
inactiv
vaccin
safe
low
durat
immun
appear
produc
predominantli
type
immun
respons
attenu
vaccin
produc
serial
passag
field
strain
passag
effect
homolog
strain
long
lead
develop
time
associ
safeti
concern
recombin
field
strain
regardless
type
vaccin
use
viremia
transmiss
pedv
prevent
vaccin
anim
outbreak
vaccin
herd
period
emerg
new
highli
pathogen
strain
uncommon
countri
vaccin
routin
use
mani
year
north
america
sprotein
base
subunit
vaccin
ipe
plu
harri
vaccin
inc
inactiv
vaccin
produc
zoeti
vidointervac
condit
licens
howev
efficaci
also
question
independ
studi
vaccin
pedv
sow
result
strong
protect
neonat
piglet
strong
need
effect
pedv
vaccin
remain
unmet
practic
feed
back
minc
intestin
infect
piglet
sow
attempt
induc
effect
immun
pedv
common
field
use
autogen
vaccin
custom
inactiv
vaccin
tailor
herd
prepar
use
sampl
provid
product
unit
also
practic
feedback
autogen
vaccin
approach
associ
signific
safeti
efficaci
issu
natur
intent
exposur
pig
age
pedv
provid
stronger
homolog
partial
heterolog
protect
vaccin
anim
less
effect
vaccin
previous
expos
pig
indic
current
vaccin
less
effect
natur
infect
prime
immun
respons
effect
boost
memori
respons
establish
viral
spike
protein
critic
protect
antigen
antispik
proteinspecif
serum
igg
level
correl
well
protect
pedv
viru
neutral
respons
howev
sprotein
base
subunit
vaccin
ipe
plu
harri
vaccin
inc
question
efficaci
indic
viral
compon
could
contribut
protect
base
hypothes
develop
process
wherebi
structur
integr
viru
maintain
viral
replic
highli
diminish
abrog
would
result
vaccin
combin
advantag
inactiv
attenu
vaccin
name
high
safeti
efficaci
margin
previous
publish
data
show
sar
coronaviru
capsid
metast
revers
denatur
chang
temperatur
ph
unfold
commenc
complet
denatur
occur
henc
studi
vaccin
develop
approach
consist
expos
pedv
virion
unfold
capsid
follow
fragment
digest
genom
rnase
diminish
viral
replic
subsequ
refold
capsid
gammairradi
pedv
virion
use
inactiv
control
vaccin
object
studi
evalu
heat
rnase
treat
pedv
vaccin
safeti
immunogen
abil
reduc
viremia
weanl
piglet
model
ultim
goal
develop
process
potenti
reduc
lead
vaccin
develop
time
safe
easili
appli
newli
emerg
strain
porcin
epidem
diarrhea
viru
pedv
strain
pedv
nation
veterinari
servic
laboratori
nvsl
ame
ia
cultur
multipl
index
moi
use
vero
cell
presenc
trypsin
previous
describ
stock
viru
titrat
three
time
obtain
mean
tissu
cultur
infecti
dose
use
spearman
karber
formula
store
aliquot
use
optim
temperatur
time
incub
dose
rnase
treatment
viru
stock
resuspend
media
ph
dilut
viru
cultur
expos
temperatur
rang
min
unfold
follow
incub
min
refold
move
h
previous
describ
sar
coronaviru
cultur
visual
electron
microscopi
ensur
structur
integr
temperatur
min
select
unfold
similarli
fragment
genom
rna
vari
combin
concentr
rnase
ameresco
rnase
thermo
scientif
test
ad
unfold
viru
cultur
follow
incub
h
treat
cultur
expos
min
refold
cool
ice
h
final
optim
protocol
consist
expos
viru
cultur
resuspend
min
follow
mgml
rnase
rnase
equival
unitsml
rnase
unitsml
rnase
incub
h
exposur
min
cool
ice
h
storag
test
final
process
test
time
ensur
reproduc
prepar
inactiv
control
vaccin
pedv
irradi
sourc
gamma
irradi
time
point
h
h
radmin
effect
dose
h
rad
use
prepar
irradi
vaccin
valid
describ
determin
effect
treatment
viabil
treat
viru
untreat
control
serial
passag
time
vero
cell
describ
passag
flask
subject
three
freezethaw
cycl
cultur
obtain
centrifug
g
min
remov
debri
one
ml
supernat
use
infect
vero
cell
monolay
also
infect
well
chamber
slide
nunc
visual
viral
replic
indirect
immunofluoresc
assay
ifa
describ
visual
viral
replic
treat
untreat
cultur
achiev
use
indirect
immunofluoresc
assay
ifa
perform
essenti
describ
previous
cultur
fix
cell
stain
polyclon
swine
antipedv
sera
nvsl
examin
fluoresc
microscop
green
cytoplasm
fluoresc
characterist
rna
viral
replic
visual
structur
treat
untreat
viral
cultur
neg
stain
standard
method
stain
grid
examin
jeol
ii
transmiss
electron
microscop
figur
possibl
genet
differ
untreat
treat
vaccin
virion
assess
deep
sequenc
heat
rnase
treat
untreat
viral
particl
purifi
infect
cell
ultracentrifug
g
h
resuspend
pb
unpackag
rna
dna
remov
rnase
dnase
cocktail
contain
unit
rnase
one
promega
unit
benzonas
novagen
unit
turbo
dnase
ambion
incub
buffer
ambion
h
viral
rna
isol
use
qiamp
viral
rna
isol
kit
qiagen
accord
manufactur
protocol
purifi
viral
rna
deep
sequenc
commerci
vendor
bgi
genom
cdna
librari
prepar
use
truseq
librari
construct
kit
illumina
inc
usa
random
hexam
primer
prepar
cdna
librari
sequenc
use
hiseq
platform
illumina
inc
usa
raw
read
bp
obtain
result
sequenc
read
analyz
bgi
genom
philadelphia
pa
raw
read
filter
use
soapnuk
get
clean
read
remov
read
adaptor
read
unknown
base
n
lowqual
read
clean
read
map
refer
pedv
genom
genbank
use
hisat
hierarch
index
splice
align
transcript
genom
map
result
analyz
use
genom
analysi
toolkit
gatk
call
singl
nucleotid
polymorph
snp
indel
insert
delet
base
snp
qualiti
score
threshold
qpred
snp
frequenc
includ
assembl
consensu
sequenc
consensu
sequenc
treat
untreat
sampl
compar
align
clustal
omega
obtain
chang
could
attribut
treatment
detect
chang
annot
includ
locat
protein
affect
tabl
clean
read
map
refer
genom
use
detect
differenti
express
gene
gene
express
level
calcul
rsem
version
differenti
express
gene
identifi
possiondi
ebseq
softwar
sampl
without
replic
anim
experiment
approv
institut
anim
care
use
committe
iacuc
dakota
state
univers
sdsu
protocol
number
specif
permiss
requir
activ
studi
involv
endang
protect
speci
twentyfour
piglet
neg
pedv
pcr
serolog
divid
group
group
control
group
n
ml
pb
intramuscular
oral
rout
group
heat
treat
pedv
vaccin
group
pedvvac
group
n
ml
intramuscular
oral
rout
group
pedv
vaccin
group
n
ml
intramuscular
oral
rout
piglet
boost
rout
dose
dpv
dpv
small
intestin
heart
liver
spleen
collect
piglet
group
n
assess
vaccin
safeti
remain
piglet
n
challeng
oral
pedv
previous
describ
postchalleng
piglet
observ
daili
clinic
sign
ped
piglet
euthan
post
challeng
dpc
dpv
three
section
small
intestin
duodenum
jejunum
ileum
collect
histopatholog
hp
immunohistochem
ihc
analysi
serum
collect
piglet
dpv
measur
bind
neutral
ab
respons
fecal
swab
collect
dpv
piglet
measur
shed
vaccin
viru
rtqpcr
fecal
swab
collect
dpv
dpc
day
piglet
measur
protect
shed
challeng
viru
rtqpcr
spike
proteinspecif
igg
respons
pig
measur
duplic
indirect
elisa
previous
describ
use
pedv
antigen
np
antigen
captur
assay
format
prevalid
anim
diseas
research
diagnost
laboratori
adrdl
sdsu
use
serum
sampl
anim
known
serolog
statu
standard
oper
procedur
follow
sampl
analysi
result
calcul
sampl
posit
sp
ratio
follow
sp
optic
densiti
od
bufferod
posit
buffer
assess
neutral
antibodi
respons
elicit
vaccin
prevalid
fluoresc
focu
neutral
ffn
assay
use
previous
describ
follow
standard
oper
procedur
adrdl
sdsu
briefli
doubl
dilut
heat
inactiv
sera
incub
foci
form
unit
incub
h
cultur
vero
cell
monolay
plate
stain
pedvspecif
fluoresceinlabel
monoclon
antibodi
visual
end
point
defin
reduct
foci
compar
control
viru
shed
fecal
rout
assess
rtqpcr
perform
ndsu
veterinari
diagnost
laboratori
use
prevalid
standard
oper
procedur
commerci
pcr
kit
call
swine
enter
pcr
panel
thermo
fisher
follow
manufactur
instruct
pig
consid
biolog
replic
n
pig
group
sacrif
assess
vaccin
safeti
prior
challeng
sampl
assess
duplic
obtain
ctvalu
convert
viral
copi
number
use
standard
curv
log
transform
represent
tissu
sampl
collect
describ
fix
neutral
buffer
formalin
h
trim
process
embed
paraffin
tissu
cut
thick
section
stain
hematoxylin
eosin
pedv
n
proteinspecif
monoclon
antibodi
immunohistochemistri
ihc
follow
standard
oper
procedur
adrdl
sdsu
score
record
blind
fashion
boardcertifi
veterinari
pathologist
score
measur
atroph
enter
characterist
ped
assign
follow
neg
mild
moder
sever
section
crypt
hypertrophi
assign
addit
point
antigen
detect
enterocyt
ihc
semiquantit
score
base
follow
criteria
neg
posit
posit
posit
consist
fecal
matter
necropsi
assign
score
follow
form
fece
semiform
fece
liquid
fece
total
score
calcul
mean
sum
histolog
fecal
score
tabl
signific
differ
treatment
assess
anova
signific
p
posthoc
analysi
use
determin
differ
group
student
ttest
use
serolog
rtqpcr
data
utest
patholog
lesion
score
mean
valu
replic
standard
deviat
statist
signific
repres
figur
tabl
achiev
target
outcom
maintain
structur
integr
achiev
diminish
viral
replic
rather
complet
inactiv
pedv
viru
cultur
first
expos
temperatur
rang
min
visual
electron
microscopi
intact
structur
detect
temperatur
test
howev
increas
number
misshapen
fragment
virion
detect
cultur
treat
remain
viabl
viral
replic
visibl
immunofluoresc
ifa
infect
vero
cell
use
pedvspecif
antibodi
without
amplif
serial
passag
viru
detect
passag
cultur
treat
viru
cultur
treat
amplifi
even
four
serial
passag
vero
cell
indic
complet
inactiv
occur
temperatur
henc
temperatur
min
chosen
revers
unfold
viral
capsid
figur
without
complet
inactiv
viru
untreat
control
viru
cultur
remain
structur
intact
expect
figur
similarli
rnase
treatment
alon
affect
viabil
reduct
viral
replic
proport
dose
time
exposur
rnase
heattreat
virion
dose
unit
rnase
unit
rnase
exposur
time
h
chosen
optim
final
vaccin
prepar
untreat
viru
control
show
robust
replic
figur
follow
heat
rnase
treatment
protocol
viral
replic
detect
passag
vero
cell
figur
gamma
irradi
inactiv
control
vaccin
typic
icosahedr
structur
seen
electron
microscopi
h
exposur
radiat
howev
coronalik
layer
contain
protect
spike
antigen
appear
damag
figur
dose
radiat
viru
detect
ifa
pedvspecif
ab
third
serial
passag
cell
cultur
figur
henc
final
dose
h
rad
select
prepar
inactiv
control
vaccin
measur
ab
respons
pedv
spike
nucleocapsid
protein
np
elisa
show
anim
vaccin
heat
rnase
treat
virion
mount
strong
ab
respons
protect
pedv
spike
antigen
follow
booster
vaccin
dpv
figur
b
howev
ab
respons
nonstructur
nucleocapsid
protein
np
remain
low
prior
challeng
pig
immun
irradi
vaccin
ab
respons
viral
antigen
low
mean
optic
densiti
valu
elisa
significantli
differ
group
figur
b
measur
viru
neutral
antibodi
fluoresc
focu
inhibit
test
ffn
show
trend
similar
spike
proteinspecif
ab
strong
viru
neutral
ab
respons
detect
anim
vaccin
heat
rnase
treat
virion
pig
receiv
irradi
viral
vaccin
differ
group
statist
signific
figur
spike
proteinspecif
ab
viru
neutral
ab
level
strongli
correl
heat
rnase
treat
pedv
vaccin
pig
correl
coeffici
expect
unvaccin
control
pig
remain
seroneg
durat
studi
assess
efficaci
vaccin
protect
challeng
shed
challeng
viral
rna
fecal
matter
assess
pedvspecif
rtqpcr
day
postchalleng
experiment
anim
rtqpcr
neg
day
postchalleng
dpc
dpc
challeng
viral
rna
detect
pig
vaccin
heat
rnase
treat
pedv
vaccin
figur
pig
administ
irradi
vaccin
posit
rtqpcr
pig
irradi
vaccin
group
turn
posit
figur
expect
viral
rna
detect
fecal
matter
unvaccin
pig
sampl
collect
day
titer
increas
dpc
viral
rna
load
significantli
differ
two
vaccin
group
time
point
signific
differ
unvaccin
control
pig
administ
irradi
vaccin
time
point
test
indic
irradi
vaccin
provid
protect
viral
replic
shed
host
examin
intestin
tissu
experiment
anim
histolog
immunohistochemistri
ihc
show
heat
rnase
treat
pedv
vaccin
complet
protect
vaccin
pig
develop
microscop
lesion
follow
challeng
characterist
microscop
intestin
lesion
atroph
enteropathi
crypt
hyperplasia
detect
duodenum
jejunum
ileum
anim
control
group
figur
viral
antigen
also
detect
enterocyt
three
section
use
pedvspecif
monoclon
abbas
immunohistochemistri
assay
figur
signific
differ
section
indic
entir
small
intestin
affect
total
microscop
score
includ
histopatholog
immunohistochemistri
score
unvaccin
anim
pig
immun
irradi
vaccin
pig
administ
heat
rnase
treat
vaccin
differ
unvaccin
group
irradi
vaccin
group
statist
signific
irradi
vaccin
appear
enhanc
intestin
patholog
tabl
similarli
total
necropsi
score
sum
fecal
histolog
score
significantli
differ
p
two
vaccin
group
unvaccin
group
irradi
vaccin
group
p
tabl
side
effect
clinic
sign
ped
observ
vaccin
pig
either
primari
booster
vaccin
vaccin
viral
rna
detect
rtqpcr
fecal
matter
vaccin
pig
group
day
primari
vaccin
week
booster
anim
remain
pcr
neg
day
challeng
therefor
although
heat
rnase
treat
pedv
virion
detect
amplif
serial
passag
vero
cell
replic
vaccin
viru
host
appear
curtail
immun
system
pig
euthan
group
prior
challeng
stool
fulli
form
necropsi
tabl
microscop
lesion
viral
antigen
detect
small
intestin
section
heart
spleen
liver
anim
necropsi
group
prior
challeng
tabl
repres
imag
duodenum
jejunum
ileum
depict
figur
identifi
possibl
mutat
could
explain
highli
effect
attenu
observ
deep
sequenc
heat
rnase
treat
virion
infect
vero
cell
result
total
mb
raw
read
obtain
rna
seq
treat
untreat
sampl
respect
clean
read
obtain
trim
gb
respect
valu
clean
read
untreat
tread
sampl
respect
indic
satisfactori
qualiti
data
obtain
list
tabl
snp
insert
delet
indel
detect
polyprotein
spike
envelop
protein
tabl
sequenc
file
supplementari
figur
heat
rnase
treat
virion
compar
untreat
virion
addit
insert
delet
detect
region
spike
protein
n
termin
signal
peptid
region
spike
protein
amino
acid
delet
one
nonsynonym
chang
posit
chang
sequenc
igen
conserv
infram
insert
detect
posit
region
chang
amino
acid
sequenc
l
lkkkgat
tabl
supplementari
figur
chemic
method
inactiv
virus
long
use
vaccin
develop
rapid
conveni
commonli
use
inactiv
agent
may
affect
nucleic
acid
also
protein
structur
henc
antigen
present
vaccin
efficaci
gamma
irradi
tradit
use
inactiv
virus
mechan
involv
includ
nucleic
acid
degrad
destruct
coval
bond
releas
free
radic
commerci
inactiv
vaccin
avail
time
test
gamma
irradi
select
method
choic
prepar
inactiv
control
vaccin
studi
moreov
similar
heat
rnase
treat
vaccin
viruslikeparticul
structur
like
maintain
gamma
irradi
achiev
complet
inactiv
gamma
irradi
previous
use
vaccin
develop
vari
success
depend
pathogen
exampl
previous
demonstr
gamma
irradi
vaccin
neospora
caninum
effect
mice
howev
gamma
irradi
lassa
viru
vaccin
fail
protect
vaccin
mice
although
approach
test
studi
target
nucleic
acid
preserv
structur
protect
outcom
vari
significantli
two
vaccin
test
possibl
releas
free
radic
irradi
process
could
deleteri
effect
integr
antigen
structur
antigen
present
vivo
detail
character
paramet
focu
futur
studi
similar
result
gamma
irradi
vaccin
studi
shown
dendrit
cell
target
spike
proteinbas
subunit
vaccin
pedv
exacerb
intestin
patholog
vaccin
pig
despit
stimul
strong
cell
respons
character
exact
physic
interact
involv
heat
rnase
treatment
within
scope
studi
find
exposur
pedv
temperatur
affect
structur
similar
studi
show
sar
coronaviru
structur
metast
revers
denatur
exposur
vari
physic
condit
ph
temperatur
although
heat
rnase
treat
viru
cultur
amplifi
passag
cell
cultur
figur
absenc
detect
rtqpcr
figur
immunohistochemistri
tabl
figur
lack
strong
ab
respons
nonstructur
np
figur
vaccin
pig
prior
challeng
indic
activ
vaccin
viral
replic
absent
host
undetect
techniqu
use
therefor
unlik
attenu
pedv
vaccin
vaccin
strategi
reli
prior
exposur
field
strain
highli
improb
revers
virul
recombin
field
strain
could
occur
heat
rnase
treat
vaccin
viral
genom
ident
untreat
parent
viru
detect
deep
sequenc
heat
rnase
treat
viru
infect
vero
cell
insert
delet
spike
protein
especi
region
influenc
pathogen
immunogen
pedv
core
neutral
epitop
pedv
spike
protein
local
amino
acid
posit
snp
identifi
spike
protein
vaccin
virion
tabl
map
residu
limit
describ
method
genet
chang
induc
treatment
repair
unpredict
repair
mutat
complement
tran
fragment
genom
could
led
detect
fluoresc
signal
passag
treatment
inde
shown
replic
defici
genom
delet
mutat
produc
serial
passag
foot
mouth
diseas
viru
fmdv
attenu
infect
present
cell
mutat
genom
complement
tran
produc
plaqu
vitro
defectivecompl
viru
system
use
vaccin
rodriguezcalvo
et
al
vaccin
viru
replic
detect
strong
protect
elicit
observ
explain
vaccin
viru
replic
host
limit
requir
coinfect
cell
even
unlik
coinfect
event
happen
despit
activ
host
innat
immun
recombin
progeni
virus
like
highli
attenu
acquir
virul
thu
provid
addit
vaccin
safeti
barrier
vivo
vivo
presenc
host
innat
immun
system
like
abl
effect
curtail
replic
despit
exposur
heat
rnase
treat
viru
cultur
detail
studi
requir
confirm
hypothes
within
scope
manuscript
import
spike
proteinspecif
antibodi
protect
pedv
wellestablish
sever
studi
describ
experiment
subunit
vector
vaccin
commerci
attenu
inactiv
vaccin
pedv
establish
strong
correl
spike
proteinspecif
antibodi
viru
neutral
titer
protect
infect
similar
studi
strong
spikeprotein
specif
ab
respons
viru
neutral
respons
note
pig
immun
heat
rnase
treat
vaccin
commerci
inactiv
vaccin
abl
reduc
challeng
viral
shed
log
attenu
vaccin
induc
iga
respons
affect
viral
shed
test
two
attenu
pedv
strain
produc
serial
passag
weanl
pig
show
passag
virus
attenu
protect
challeng
viral
shed
clinic
sign
direct
comparison
possibl
due
differ
experiment
condit
unlik
cite
studi
intestin
lesion
challeng
viru
detect
qpcr
heat
rnase
treat
vaccin
group
studi
although
booster
incorpor
studi
design
minim
risk
like
requir
achiev
adequ
protect
strong
spike
protein
specif
antibodi
respons
viru
neutral
respons
detect
first
dose
heat
rnase
treat
vaccin
dpv
figur
cell
mediat
immun
assess
due
difficulti
transport
cell
like
compromis
process
use
heat
rnase
treat
vaccin
effect
prevent
challeng
viral
replic
vaccin
pig
ideal
pedv
studi
vaccin
efficaci
pregnant
sow
neonat
pig
expens
procedur
tediou
although
clinic
sign
less
sever
older
piglet
virul
vari
isol
use
challeng
pedv
infect
replic
well
pig
age
henc
sever
research
use
weanl
piglet
screen
vaccin
candid
efficaci
safeti
approach
help
reduc
anim
use
cost
candid
fall
short
expect
sever
swine
bioassay
studi
grow
piglet
report
peak
pedv
replic
occur
dpi
dpi
viral
load
decreas
similar
pattern
infect
observ
studi
uninfect
control
pig
mean
fecal
viral
rna
load
log
copi
number
dpi
figur
develop
microscop
lesion
sever
clinic
sign
comparison
untreat
control
irradi
vaccin
group
fecal
viral
shed
intestin
patholog
detect
pig
immun
heat
rnase
treat
vaccin
indic
vaccin
induc
immun
highli
effect
pedv
challeng
within
limit
weanl
pig
studi
model
primari
advantag
innov
approach
safeti
efficaci
conveni
short
develop
time
method
easili
adapt
newli
evolv
strain
provid
readili
cultur
approach
relev
current
field
immun
practic
feedback
exposur
autogen
vaccin
futur
goal
includ
test
heat
rnase
treat
vaccin
pregnant
sow
improv
oral
respiratori
mucos
vaccin
deliveri
system
target
improv
protect
dataset
gener
studi
avail
request
correspond
author
anim
studi
review
approv
institut
anim
care
use
committe
iacuc
dakota
state
univers
sdsu
protocol
number
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
describ
technolog
cover
provision
us
patent
applic
serial
